Reported covered position: VICE PRESIDENT OF GOVERNMENT RELATIONS
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Affordable Access to Prescription Medications Act of 2009
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
FDA Drug Approval regulations, coverage of off label medications, reducing out of pocket costs, S. 1630, health care reform, CDC National Lupus Patient Registry, Peer Reviewed Medical Research funding through DoD, Comparative Effectiveness research at AHRQ and IOM
Lupus Research, Education, Awareness, Communication, and Healthcare Amendments of 2007
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2010 · first_quarter · Q1
Surgeon General and lupus; CDC National Lupus Patient Registry; Medicare Part D; Medical research funding through Defense Health; OWH Lupus Awareness Campaign; NIH and lupus research
Filing targets: Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2009 · fourth_quarter · Q4
Source: Senate LDA
Appropriations for FDA, CDC, NIH, and Dod(Peer Review Medical Research); National Lupus Patient Registry; Impact of Fluorescent Lights on people with lupus; CMS: Medicare and Medicaid; Social Security Disability Regualtions; Medicare Part D; Lupus REACH Amendments Act, S. 1359/H.R. 1192
Lupus Research, Education, Awareness, Communication, and Healthcare Amendments of 2007
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
Appropriations for DHHS, FDA, CDC, NIH, and DoD(Peer Review Medical Research) FDA Lupus Guidance Document, new therapies for lupus, biomarkers, definitions of lupus flares Federal Working Group on Lupus; National Lupus Patient Registry; Implementation of Medicare Modernization Act; Social Security Disability Regulations; Medicare Part D Regulations; federal budget resolution; Lupus REACH Amendments Act, S. 1359/H.R. 1192
Lupus Research, Education, Awareness, Communication, and Healthcare Amendments of 2007
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
Appropriations for FDA, CDC, NIH, and DoD(Peer Review Medical Research); FDA Lupus Guidance Document, new therapies for lupus, biomarkers, definitions of lupus flares; Federal Working Group on Lupus; National Lupus Patient Registry; Implementation of Medicare Modernization Act; Social Security Disability Regulations; Medicare Part D Regulations; federal budget resolution; Lupus REACH Amendments Act, S. 1359/H.R. 1192; Impact of fluorescent lights on people with lupus
Lupus Research, Education, Awareness, Communication, and Healthcare Amendments of 2007
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
Appropriations for FDA, CDC, NIH, and DoD(Peer Review Medical Research); FDA Lupus Guidance Document, new therapies for lupus, biomarkers, definitions of lupus flares; Federal Working Group on Lupus; National Lupus Patient Registry; Implementation of Medicare Modernization Act; Social Security Disability Regulations; Medicare Part D Regulations; federal budget resolution; Lupus REACH Amendments Act, S. 1359/H.R. 1192; Impact of fluorescent lights on people with lupus
Lupus Research, Education, Awareness, Communication, and Healthcare Amendments of 2007
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
Appropriations for FDA, CDC, NIH, and Dod(Peer Review Medical Research); National Lupus Patient Registry; Impact of Fluorescent Lights on people with lupus; CMS: Medicare and Medicaid; Social Security Disability Regualtions; Medicare Part D; Lupus REACH Amendments Act, S. 1359/H.R. 1192
Lupus Research, Education, Awareness, Communication, and Healthcare Amendments of 2007
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
Appropriations for DHHS, FDA, CDC, NIH, and DoD(Peer Review Medical Research) FDA Lupus Guidance Document, new therapies for lupus, biomarkers, definitions of lupus flares Federal Working Group on Lupus; National Lupus Patient Registry; Implementation of Medicare Modernization Act; Social Security Disability Regulations; Medicare Part D Regulations; federal budget resolution; Lupus REACH Amendments Act, S. 1359/H.R. 1192
Lupus Research, Education, Awareness, Communication, and Healthcare Amendments of 2007
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
Appropriations for DHHS, FDA, CDC, NIH, and DoD FDA Lupus Guidance Document, new therapies for lupus, biomarkers, definitions of lupus flares Federal Working Group on Lupus; National Lupus Patient Registry; Implementation of Medicare Modernization Act; Social Security Disability Regulations; Medicare Part D Regulations; federal budget resolution; Lupus REACH Amendments Act, S. 1359/H.R. 1192
Lupus Research, Education, Awareness, Communication, and Healthcare Amendments of 2007
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
Appropriations for DHHS, FDA, CDC, NIH, and DoD FDA Lupus Guidance Document, new therapies for lupus, biomarkers, definitions of lupus flares Federal Working Group on Lupus; National Lupus Patient Registry; Implementation of Medicare Modernization Act; Social Security Disability Regulations; Medicare Part D Regulations; federal budget resolution; Lupus REACH Amendments Act, S. 1359/H.R. 1192
FDA Drug Approval regulations; CDC National Lupus Patient Registry; Medicare Part B and Part D; Peer Reviewed Medical Research funding through DoD; CDC National Lupus Patient Registry; OWH Lupus Awareness Campaign
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2009 · third_quarter · Q3
FDA Drug Approval regulations, coverage of off label medications, reducing out of pocket costs, S. 1630, health care reform, CDC National Lupus Patient Registry, Peer Reviewed Medical Research funding through DoD, Comparative Effectiveness research at AHRQ and IOM
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2009 · second_quarter · Q2
FDA Drug Approval, Coverage of off label medications, Medicare Part D, CDC National Lupus Patient Registry, NIH funding and lupus research, Comparative Effectiveness Research at AHRQ and IOM, Health Care Reform
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2009 · first_quarter · Q1
FDA Drug Approval, Impact of Fluorescent Lights on People with Lupus, Medicare Part D, CDC, NIH Funding, asking for a Surgeon General's report on the gaps in lupus research, Comparative Effectiveness Research at AHRQ & IOM
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2008 · fourth_quarter · Q4
FDA Drug Approval, Impact of Fluorescent Lights on People with Lupus, Medicare Part D, CDC, NIH Funding
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2008 · third_quarter · Q3
Appropriations for FDA, CDC, NIH, and Dod(Peer Review Medical Research); National Lupus Patient Registry; Impact of Fluorescent Lights on people with lupus; CMS: Medicare and Medicaid; Social Security Disability Regualtions; Medicare Part D; Lupus REACH Amendments Act, S. 1359/H.R. 1192
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2008 · second_quarter · Q2
Appropriations for FDA, CDC, NIH, and DoD(Peer Review Medical Research); FDA Lupus Guidance Document, new therapies for lupus, biomarkers, definitions of lupus flares; Federal Working Group on Lupus; National Lupus Patient Registry; Implementation of Medicare Modernization Act; Social Security Disability Regulations; Medicare Part D Regulations; federal budget resolution; Lupus REACH Amendments Act, S. 1359/H.R. 1192; Impact of fluorescent lights on people with lupus
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, White House Office
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2008 · first_quarter · Q1
Appropriations for DHHS, FDA, CDC, NIH, and DoD(Peer Review Medical Research) FDA Lupus Guidance Document, new therapies for lupus, biomarkers, definitions of lupus flares Federal Working Group on Lupus; National Lupus Patient Registry; Implementation of Medicare Modernization Act; Social Security Disability Regulations; Medicare Part D Regulations; federal budget resolution; Lupus REACH Amendments Act, S. 1359/H.R. 1192
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), White House Office
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2007 · year_end · YY
Appropriations for DHHS, FDA, CDC, NIH, and DoD FDA Lupus Guidance Document, new therapies for lupus, biomarkers, definitions of lupus flares Federal Working Group on Lupus; National Lupus Patient Registry; Implementation of Medicare Modernization Act; Social Security Disability Regulations; Medicare Part D Regulations; federal budget resolution; Lupus REACH Amendments Act, S. 1359/H.R. 1192
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), White House Office